Florida Breckenridge, Inc. v. Solvay Pharmaceuticals, Inc., 98-4606

Decision Date11 May 1999
Docket NumberNo. 98-4606,98-4606
Parties1999-1 Trade Cases P 72,519, 50 U.S.P.Q.2d 1761, 12 Fla. L. Weekly Fed. C 853 FLORIDA BRECKENRIDGE, INC. d.b.a. Breckenridge Pharmaceutical, Inc., Plaintiff-Counterclaim-Defendant-Appellee, v. SOLVAY PHARMACEUTICALS, INC., a Georgia corporation, Defendant-Counterclaim-Plaintiff-Appellant,
CourtU.S. Court of Appeals — Eleventh Circuit
NOTE: THE COURT HAS WITHDRAWN THIS OPINION

To continue reading

Request your trial
4 cases
  • Healthpoint, Ltd. v. Ethex Corp.
    • United States
    • U.S. District Court — Western District of Texas
    • July 12, 2001
    ...that Accuzyme is not marketed lawfully, Ethex would be required to withdraw Ethezyme as well. Ethex argues that the FDA's position in the Solvay brief is entitled to no deference from the Court, but if it is considered, Accuzyme cannot meet the test for the GRAS/E or grandfather exceptions ......
  • Healthpoint, Ltd. v. Stratus Pharmaceuticals, Inc.
    • United States
    • U.S. District Court — Western District of Texas
    • June 1, 2001
    ...in the FDA's regulations, the Orange Book, and encompassed by CDER's definition of "generic." As urged by the FDA in its amicus brief in Solvay, to allow a drug manufacturer to use the word "generic" to mean something different for unapproved and approved drugs will confuse the Although the......
  • Migdalia M v. Saul
    • United States
    • U.S. District Court — Northern District of Illinois
    • October 28, 2019
    ..., 313 Fed.Appx. 851, 853 (7th Cir. 2009) ; U.S. v. Kozinski , 16 F.3d 795, 811 (7th Cir. 1994) ; Florida Breckenridge, Inc. v. Solvay Pharm., Inc. , 174 F.3d 1227, 1233-34 (11th Cir. 1999).Plaintiff also claims she required a crutch for ambulation for months [Dkt. # 16, at 10], but of cours......
  • U.S. v. Sage Pharmaceuticals, 99-30425
    • United States
    • United States Courts of Appeals. United States Court of Appeals (5th Circuit)
    • April 20, 2000
    ...a notice was published in the federal register and a supplemental NDA was approved for the drug. Florida Breckenridge, Inc. v. Solvay Pharmaceuticals, Inc., 174 F.3d 1227, 1229 (11th Cir. 1999), withdrawn at the request of the The DESI program was the basis for a short-lived policy under wh......
1 books & journal articles
  • Tell the truth.
    • United States
    • Florida Bar Journal Vol. 75 No. 11, December 2001
    • December 1, 2001
    ...re Disciplinary Action Boucher, 837 F.2d 869, 871 (9th Cir. 1988). (20) See Florida Breckenridge, Inc. v. Solvay Pharmaceuticals, Inc., 174 F.3d 1227 (11th Cir. 1999) (opinion withdrawn from bound volume at court's request). (21) Id. at * 7. (22) 174 F.3d at * 8. (23) Arizonans for Official......

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT